abstract |
The invention provides the use of a spirostanyl glycoside of formula I, <CHEM> wherein Q<1>, Q<4> and Q<5> are each methylene; Q<2> is carbonyl, methylene, <CHEM> Q<3> is <CHEM> and R<1> is a specified glycosidic group; with various provisos; in the manufacture of a medicament for the treatment of hypercholesterolemia or atherosclerosis. |